fat loss
Quality Rating
Buy Cagri-Sema Blend 10mg
CagriSema — amylin + GLP-1 dual mechanism for 22.7% weight loss
22.7% weight loss Phase 3Dual amylin + GLP-1Single vial convenience
Who This Is For
Users who have plateaued on semaglutide or want the clinical Phase 3 CagriSema combination from one vial.
Overview & Benefits
CagriSema combines Cagrilintide and Semaglutide — the dual amylin + GLP-1 mechanism that produced 22.7% mean weight loss at 68 weeks in Novo Nordisk's Phase 3 REDEFINE trial. The pre-blended vial eliminates the need to reconstitute both peptides separately. The amylin pathway adds slowed gastric emptying, glucagon suppression, and central satiety signals that are additive to GLP-1's appetite reduction — producing substantially more weight loss than either compound alone.
Key Benefits
- 22.7% mean weight loss in Phase 3 REDEFINE trial
- Dual amylin + GLP-1 mechanism — additive appetite suppression
- Pre-blended for single reconstitution convenience
- More weight loss than semaglutide or cagrilintide alone
- Once-weekly injection protocol
Protocols & Dosing
Weekly CagriSema Protocol
Once weeklyStart 0.5mg/0.5mg weekly, titrate to 2.4mg/2.4mg over 12–16 weeks
Titrate slowly to avoid GI side effects. Monitor for nausea and adjust pace accordingly.
Buy Cagri-Sema Blend 10mg
$179.99
Buy Now — $179.99Buy at PhiogenResearch-grade · COA verified · Phiogen
Categoryfat loss
Typeinjectable
Quality Rating★★★★★
VendorPhiogen
Also Needed
Cagri-Sema Blend 10mg
$179.99